Afeyan Noubar's Form 4 filing
Seres Therapeutics, Inc. (MCRB) · filed Jul 7, 2022
- Accession no.
- 0000899243-22-025721
- Filed
- Jul 7, 2022, 5:00 PM ET
- Trade date
- Jul 5, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market purchases total $27.5M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Afeyan NoubarCIK 0001222012 | 10% Owner |
| Flagship Pioneering, LLCCIK 0001400240 | 10% Owner |
| Nutritional Health LTP Fund General Partner LLCCIK 0001780951 | 10% Owner |
| Nutritional Health LTP Fund, L.P.CIK 0001780956 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 5, 2022 | Common Stock | PPurchaseAcquired | +2,912,748 | $3.15 | +$9,175,156.2 | 5,875,711 | Indirect | |
| Jul 5, 2022 | Common Stock | PPurchaseAcquired | +5,825,495 | $3.15 | +$18,350,309.25 | 5,825,495 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.